H
Henry R. Black
Researcher at Rush University Medical Center
Publications - 207
Citations - 92296
Henry R. Black is an academic researcher from Rush University Medical Center. The author has contributed to research in topics: Blood pressure & Prehypertension. The author has an hindex of 74, co-authored 206 publications receiving 88350 citations. Previous affiliations of Henry R. Black include University of Erlangen-Nuremberg.
Papers
More filters
Journal ArticleDOI
Exercise Capacity and the Risk of Death in Women The St James Women Take Heart Project
Martha Gulati,Dilip K. Pandey,Morton F. Arnsdorf,Diane S. Lauderdale,Ronald A. Thisted,Roxanne H. Wicklund,Arfan J. Al-Hani,Henry R. Black +7 more
TL;DR: This study confirms that exercise capacity is an independent predictor of death in asymptomatic women, greater than what has been previously established among men.
Journal ArticleDOI
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Henry R. Black,William J. Elliott,Gregory A Grandits,Patricia Grambsch,Tracy Lucente,William B. White,James D. Neaton,Richard H. Grimm,Lennart Hansson,Yves Lacourcière,James E. Muller,Peter Sleight,Michael A. Weber,Gordon H. Williams,Janet Wittes,Alberto Zanchetti,Robert J. Anders +16 more
TL;DR: The CONVINCE trial did not demonstrate equivalence of a COER verapamil–based antihypertensive regimen compared with a regimen beginning with a diuretic or -blocker, and data indicate that the effectiveness of calcium-channel therapy in reducing cardiovascular disease is similar but not better than diuresis treatment.
Journal ArticleDOI
Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension
John B. Kostis,Barry R. Davis,Jeffrey A. Cutler,Richard H. Grimm,Kenneth G. Berge,Cohen Jd,Clifton R. Lacy,Horace M. Perry,Blaufox,Sylvia Wassertheil-Smoller,Henry R. Black,Eleanor Schron,Berkson Dm,Curb Jd,W M Smith,Robert H. McDonald,William B. Applegate +16 more
TL;DR: In older persons with isolated systolic hypertension, stepped-care treatment based on low-dose chlorthalidone exerted a strong protective effect in preventing heart failure, and among patients with prior MI, an 80% risk reduction was observed.
Journal ArticleDOI
Low-Fat Dietary Pattern and Risk of Colorectal Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial
Shirley A.A. Beresford,Karen C. Johnson,Cheryl Ritenbaugh,Norman L. Lasser,Linda Snetselaar,Henry R. Black,Garnet L. Anderson,Annlouise R. Assaf,Annlouise R. Assaf,Tamsen Bassford,Deborah J. Bowen,Robert L. Brunner,Robert G. Brzyski,Bette J. Caan,Rowan T. Chlebowski,Margery Gass,Rosanne C. Harrigan,Jennifer Hays,David Heber,Gerardo Heiss,Susan L. Hendrix,Barbara V. Howard,Judith Hsia,F. Allan Hubbell,Rebecca D. Jackson,Jane Morley Kotchen,Lewis H. Kuller,Andrea Z. LaCroix,Dorothy S. Lane,Robert Langer,Cora E. Lewis,JoAnn E. Manson,Karen L. Margolis,Yasmin Mossavar-Rahmani,Judith K. Ockene,Linda M. Parker,Michael G. Perri,Lawrence S. Phillips,Ross L. Prentice,John A Robbins,Jacques E. Rossouw,Gloria E. Sarto,Marcia L. Stefanick,Linda Van Horn,Mara Z. Vitolins,Jean Wactawski-Wende,Robert B. Wallace,Evelyn P Whitlock +47 more
TL;DR: A low-fat dietary pattern intervention did not reduce the risk of colorectal cancer in postmenopausal women during 8.1 years of follow-up, and secondary analyses suggested potential interactions with baseline aspirin use and combined estrogen-progestin use status.
Journal ArticleDOI
Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Barry R. Davis,Jeffrey A. Cutler,David Gordon,Curt D. Furberg,Jackson T. Wright,William C. Cushman,Richard H. Grimm,John C. LaRosa,Paul K. Whelton,H. Mitchell Perry,Michael H. Alderman,Charles E. Ford,Suzanne Oparil,Charles K. Francis,Michael A. Proschan,Sara L. Pressel,Henry R. Black,C. Morton Hawkins +17 more
TL;DR: The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), a randomized, double-blind trial in 40,000 high-risk hypertensive patients, is designed to determine whether the combined incidence of fatal coronary heart disease (CHD) and nonfatal myocardial infarction differs between persons randomized to diuretic treatment and each of three alternative treatments.